We are live on ! Find out more
VRX

VALEANT PHARMACEUTICALS INTL
VRX

Delisted

VRX was delisted on the 27th of September, 2010.

Back to rankings

2 hedge funds and large institutions have $846K invested in VALEANT PHARMACEUTICALS INTL in 2013 Q2 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
2
Holders Change
+2
Holders Change %
–
% of All Funds
0.07%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
LWI
1
Long Wharf Investors
Massachusetts
$843K +$843K +9,795 New
TWA
2
TCI Wealth Advisors
Arizona
$3K +$3K +31 New

VRX Hedge Fund Activity: Q2 2013 in Review

2 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in VALEANT PHARMACEUTICALS INTL (VRX) for Q2 2013, worth a combined $846K.

Buyers outnumbered sellers: 2 funds opened new VRX positions and 0 closed out — a net gain of 2 holders — while 0 added to existing stakes and 0 trimmed.

  • 2 institutional investors held VALEANT PHARMACEUTICALS INTL (VRX) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $846K of VALEANT PHARMACEUTICALS INTL stock for Q2 2013.
  • 2 funds opened new VALEANT PHARMACEUTICALS INTL positions in Q2 2013 and 0 closed out, a net change of +2 holders.

Based on aggregated 13F filings for Q2 2013.